Overall Status

Recruiting (3)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Memorial Sloan Kettering Cancer Center (1)

National Cancer Institute (NCI) (1)

University of Aarhus (1)

Collaborator

Department of Clinical Medicine, Aarhus University (1)

Department of Gynaecology and Obstetrics, Aarhus University Hospital (1)

Department of Gynaecology and Obstetrics, Goedstrup Regional Hospital (1)

Department of Gynaecology and Obstetrics, Horsens Regional Hospital (1)

Department of Gynaecology and Obstetrics, Randers Regional Hospital (1)

Department of Gynaecology and Obstetrics, Viborg Regional Hospital (1)

Intervention

biopsy (1)

biospecimen collection (1)

computed tomography (1)

laboratory biomarker analysis (1)

mq719 (1)

nivolumab (1)

pembrolizumab (1)

positron emission mammography (1)

talimogene laherparepvec (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

procedure (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (2)

Observational (1)

adnexal carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

Recruiting

Cutaneous Squamous Cell Carcinoma
+18 more

MQ719
Pembrolizumab

Basking Ridge, New Jersey
+6 more

May 18, 2023

Improved Diagnosis of Ovarian Cancer

Recruiting

Ovarian Neoplasms
+6 more

Aarhus, Denmark

Department of Gynaecology and Obstetrics, Aarhus University Hosp

May 1, 2023

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting

Adenoid Cystic Skin Carcinoma
+38 more

Biopsy
+6 more

Los Angeles, California
+35 more

Jan 31, 2023